ALTUVOCT 2 000 IU powder and solvent for solution for injection, ALTUVOCT 3 000 IU powder and solvent for solution for injection, ALTUVOCT 4 000 IU powder and solvent for solution for injection, ALTUVOCT 250 IU powder and solvent for solution for injection, ALTUVOCT 1 000 IU powder and solvent for solution for injection, ALTUVOCT 500 IU powder and solvent for solution for injection
Sobi.BIVV001-002
Phase 3 small_molecule active
Quick answer
ALTUVOCT 2 000 IU powder and solvent for solution for injection, ALTUVOCT 3 000 IU powder and solvent for solution for injection, ALTUVOCT 4 000 IU powder and solvent for solution for injection, ALTUVOCT 250 IU powder and solvent for solution for injection, ALTUVOCT 1 000 IU powder and solvent for solution for injection, ALTUVOCT 500 IU powder and solvent for solution for injection for Haemophilia A is a Phase 3 program (small_molecule) at Swedish Orphan Biovitrum AB (publ) with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Swedish Orphan Biovitrum AB (publ)
- Indication
- Haemophilia A
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active